Ian Mortimer
Vorstandsvorsitzender bei XENON PHARMACEUTICALS INC.
Vermögen: 2 Mio $ am 30.04.2024
Profil
Ian C.
Mortimer is currently the President, Chief Executive Officer & Director at Xenon Pharmaceuticals, Inc. He is also the President, Treasurer & Director at Xenon Pharmaceuticals USA, Inc. Additionally, he serves as the Director at Perimeter Medical Imaging AI, Inc. Mr. Mortimer previously worked as an Independent Director at Appili Therapeutics, Inc. and as a Director at Perimeter Medical Imaging, Inc. Prior to that, he was the Chief Financial Officer & Executive Vice President at Arbutus Biopharma Corp.
Mr. Mortimer holds an MBA from Queen's University and an undergraduate degree from the University of British Columbia.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 05.04.2024 | 45 602 ( 0,06% ) | 2 Mio $ | 30.04.2024 | |
| 03.04.2024 | 113 333 ( 0,17% ) | 57 006 $ | 30.04.2024 |
Aktive Positionen von Ian Mortimer
| Unternehmen | Position | Beginn |
|---|---|---|
| XENON PHARMACEUTICALS INC. | Vorstandsvorsitzender | 03.06.2021 |
| PERIMETER MEDICAL IMAGING AI, INC. | Direktor/Vorstandsmitglied | 03.07.2020 |
Xenon Pharmaceuticals USA, Inc.
 Xenon Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Xenon Pharmaceuticals USA, Inc. develops clinical-stage biopharmaceutical products. The company is headquartered in Boston, PA. | Präsident | - |
Ehemalige bekannte Positionen von Ian Mortimer
| Unternehmen | Position | Ende |
|---|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Finanzdirektor/CFO | 01.10.2013 |
| ARBUTUS BIOPHARMA CORPORATION | Finanzdirektor/CFO | 01.10.2013 |
Perimeter Medical Imaging, Inc.
 Perimeter Medical Imaging, Inc. Medical SpecialtiesHealth Technology Perimeter Medical Imaging, Inc. provides medical services. It develops, patents and commercializes surgical imaging tools that allow surgeons, radiologists, and pathologists to assess microscopic tissue structures during surgical procedures. It offers OTIS Optical Tissue Imaging Console, OTIS Tissue Immobilization System, OTIS Proprietary Imaging Atlas, and Next Generation OTIS AI Tissue Assessment Algorithms. The company was founded by Elizabeth Munro, David Rempel, Andrew Berkeley, Arsen R. Hajian, and Gordon Cheung in 2013 and is headquartered in Toronto, Canada. | Direktor/Vorstandsmitglied | - |
| APPILI THERAPEUTICS INC. | Vorsitzender | - |
Ausbildung von Ian Mortimer
| University of British Columbia | Undergraduate Degree |
| Queen's University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Health Technology |
| XENON PHARMACEUTICALS INC. | Health Technology |
| APPILI THERAPEUTICS INC. | Health Technology |
| PERIMETER MEDICAL IMAGING AI, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Xenon Pharmaceuticals USA, Inc.
Xenon Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Xenon Pharmaceuticals USA, Inc. develops clinical-stage biopharmaceutical products. The company is headquartered in Boston, PA. | Health Technology |
Perimeter Medical Imaging, Inc.
Perimeter Medical Imaging, Inc. Medical SpecialtiesHealth Technology Perimeter Medical Imaging, Inc. provides medical services. It develops, patents and commercializes surgical imaging tools that allow surgeons, radiologists, and pathologists to assess microscopic tissue structures during surgical procedures. It offers OTIS Optical Tissue Imaging Console, OTIS Tissue Immobilization System, OTIS Proprietary Imaging Atlas, and Next Generation OTIS AI Tissue Assessment Algorithms. The company was founded by Elizabeth Munro, David Rempel, Andrew Berkeley, Arsen R. Hajian, and Gordon Cheung in 2013 and is headquartered in Toronto, Canada. | Health Technology |
